An in vitro study has shown that indoxyl sulfate, a tryptophan metabolite, acting through the aryl hydrocarbon receptor and pregnane-X-receptor, not only reduced the severity of breast cancer but also inhibited the proliferation of breast cancer cells (41). This evidence concerns the gene NR1I2 and breast carcinoma.